Fig. 1From: The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritisPlasma concentrations of MIV-711 in rabbits on Day 1, Day 10, Week 4 and Week 7 after oral administration of MIV-711 once daily at a 30 µmol/kg and b 100 µmol/kg. Mean ± SEM, n = 3–7 per time pointBack to article page